Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87816043 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Claudia A. Smith |
Attorney Name | Claudia A. Smith |
Attorney Docket Number | 1101391-0285 |
Law Office Assigned | M20 |
Employee Name | ERVIN, INGA MARIE |
2018-03-01 | Application Filed |
2018-07-24 | Published for Opposition |
2018-09-18 | Location: INTENT TO USE SECTION |
2019-08-16 | Status: Live/Pending |
2019-08-20 | Transaction Date |
Owner: | ![]() |
Entity Statement | aktieselskab (a/s) |
Address | Ottiliavej 9 2500 Valby DK |
Legal Entity Type | |
Legal Entity State | DK |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0051 | Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-03-05 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-08 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-05-24 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2018-05-24 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2018-05-24 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-05-24 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-05-31 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-05-31 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-06-01 | 9 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-06-04 | 10 CNSA P: |
ASSIGNED TO LIE | 2018-06-15 | 11 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-07-04 | 12 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2018-07-24 | 13 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-07-24 | 14 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-09-18 | 15 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-02-28 | 16 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2019-02-28 | 17 EXT1 S: |
EXTENSION 1 GRANTED | 2019-02-28 | 18 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-03-02 | 19 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-08-16 | 20 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2019-08-16 | 21 EXT2 S: |
EXTENSION 2 GRANTED | 2019-08-16 | 22 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-20 | 23 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-02-21 | 24 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2020-02-21 | 25 EXT3 S: |
EXTENSION 3 GRANTED | 2020-02-21 | 26 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-02-29 | 27 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-08-31 | 28 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2020-08-31 | 29 EXT4 S: |
EXTENSION 4 GRANTED | 2020-08-31 | 30 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-02 | 31 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2021-02-18 | 32 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-03-09 | 33 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2021-02-18 | 34 EXT5 S: |
EXTENSION 5 GRANTED | 2021-03-11 | 35 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-12 | 36 EXRA E:E-Mail |
TEAS EXPRESS ABANDONMENT RECEIVED | 2021-09-02 | 37 EXAR I:Incoming Correspondence |
ABANDONMENT - AFTER PUBLICATION | 2021-09-03 | 38 ABN5 O:Outgoing Correspondence |
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2021-09-03 | 39 MAB5 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.